DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Rossari Biotech Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 2 hrs ago·14 Oct 2026, 1:19 pm

Rossari Biotech

Rossari Biotech has announced its upcoming earnings conference call scheduled for Monday, October 19, 2026, at 4:00 PM IST. This virtual meeting is designed for institutional investors, analysts, and the general public to discuss the company's recent financial performance and future outlook.

For investors, this event is a key opportunity to gain clarity on the company's operational strategy and potential growth drivers. The management's commentary during the call often provides insights into market trends and operational efficiency, which can be crucial for assessing the stock's future trajectory.

Investors should watch for updates on revenue growth, cost management, and any guidance provided by the company regarding its upcoming quarters. This information will help in forming a more informed view of the company's health and its potential to deliver value in the market.